63 related articles for article (PubMed ID: 9252983)
1. Adenosine A2A agonists: a potential new type of atypical antipsychotic.
Rimondini R; Ferré S; Ogren SO; Fuxe K
Neuropsychopharmacology; 1997 Aug; 17(2):82-91. PubMed ID: 9252983
[TBL] [Abstract][Full Text] [Related]
2. CD73 polymorphisms are associated with schizophrenia.
Peng HX; Zhang LL; Jiang D; Jian N; Zhang TM; Luo JG; Yin HY
Purinergic Signal; 2024 May; ():. PubMed ID: 38758511
[TBL] [Abstract][Full Text] [Related]
3. Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia.
Sahay S; Devine EA; McCullumsmith RE; O'Donovan SM
Cells; 2023 Dec; 13(1):. PubMed ID: 38201235
[TBL] [Abstract][Full Text] [Related]
4. Impact of an Adenosine A
Prasad K; de Vries EFJ; Sijbesma JWA; Garcia-Varela L; Vazquez-Matias DA; Moraga-Amaro R; Willemsen ATM; Dierckx RAJO; van Waarde A
Mol Pharm; 2022 Aug; 19(8):2992-3001. PubMed ID: 35849844
[TBL] [Abstract][Full Text] [Related]
5. Selective Manipulation of G-Protein γ
Brunori G; Pelletier OB; Stauffer AM; Robishaw JD
J Neurosci; 2021 Nov; 41(44):9065-9081. PubMed ID: 34544837
[TBL] [Abstract][Full Text] [Related]
6. Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
Beggiato S; Zuccarini M; Cassano T; Borroto-Escuela DO; Di Iorio P; Schwarcz R; Fuxe K; Ferraro L
Front Pharmacol; 2021; 12():654426. PubMed ID: 33935767
[No Abstract] [Full Text] [Related]
7. Allosteric Interactions between Adenosine A
Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A
Wydra K; Gawliński D; Gawlińska K; Frankowska M; Borroto-Escuela DO; Fuxe K; Filip M
Cells; 2020 Jun; 9(6):. PubMed ID: 32492952
[TBL] [Abstract][Full Text] [Related]
9. Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia.
Borroto-Escuela DO; Ferraro L; Narvaez M; Tanganelli S; Beggiato S; Liu F; Rivera A; Fuxe K
Cells; 2020 Apr; 9(5):. PubMed ID: 32349279
[TBL] [Abstract][Full Text] [Related]
10. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.
Petković B; Kesić S; Pešić V
Curr Pharm Des; 2020; 26(4):466-484. PubMed ID: 31939725
[TBL] [Abstract][Full Text] [Related]
11. Behavioral Effects of a Potential Novel TAAR1 Antagonist.
Lam VM; Mielnik CA; Baimel C; Beerepoot P; Espinoza S; Sukhanov I; Horsfall W; Gainetdinov RR; Borgland SL; Ramsey AJ; Salahpour A
Front Pharmacol; 2018; 9():953. PubMed ID: 30233365
[TBL] [Abstract][Full Text] [Related]
12. The Role of Adenosine Receptors in Psychostimulant Addiction.
Ballesteros-Yáñez I; Castillo CA; Merighi S; Gessi S
Front Pharmacol; 2017; 8():985. PubMed ID: 29375384
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease.
Borroto-Escuela DO; Carlsson J; Ambrogini P; Narváez M; Wydra K; Tarakanov AO; Li X; Millón C; Ferraro L; Cuppini R; Tanganelli S; Liu F; Filip M; Diaz-Cabiale Z; Fuxe K
Front Cell Neurosci; 2017; 11():37. PubMed ID: 28270751
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes.
Borroto-Escuela DO; Wydra K; Pintsuk J; Narvaez M; Corrales F; Zaniewska M; Agnati LF; Franco R; Tanganelli S; Ferraro L; Filip M; Fuxe K
Neural Plast; 2016; 2016():4827268. PubMed ID: 27872762
[TBL] [Abstract][Full Text] [Related]
15. Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia.
Borroto-Escuela DO; Pintsuk J; Schäfer T; Friedland K; Ferraro L; Tanganelli S; Liu F; Fuxe K
Ther Adv Psychopharmacol; 2016 Apr; 6(2):77-94. PubMed ID: 27141290
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.
Ferré S
Psychopharmacology (Berl); 2016 May; 233(10):1963-79. PubMed ID: 26786412
[TBL] [Abstract][Full Text] [Related]
17. Activation of adenosine A₂A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation.
Simola N; Costa G; Morelli M
Psychopharmacology (Berl); 2016 Feb; 233(3):507-19. PubMed ID: 26564233
[TBL] [Abstract][Full Text] [Related]
18. Novel Therapeutic GPCRs for Psychiatric Disorders.
Komatsu H
Int J Mol Sci; 2015 Jun; 16(6):14109-21. PubMed ID: 26101869
[TBL] [Abstract][Full Text] [Related]
19. Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Matos M; Shen HY; Augusto E; Wang Y; Wei CJ; Wang YT; Agostinho P; Boison D; Cunha RA; Chen JF
Biol Psychiatry; 2015 Dec; 78(11):763-74. PubMed ID: 25869810
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors - IUPHAR Review 13.
Beaulieu JM; Espinoza S; Gainetdinov RR
Br J Pharmacol; 2015 Jan; 172(1):1-23. PubMed ID: 25671228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
